GSK2256098

未知生产厂商

GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas).

技术标识符

化学式: C₂₀H₂₃ClN₆O₂
CAS 编号: 1224887-10-8
UNII ID: R7O0O4110G

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation
US 12257251 B2申请人: INXMED NANJING CO LTD优先权: 2019
CN
US
2 件公开

药物